Medical and Scientific Consulting
The Lupus Therapeutics Consulting service, part of our full suite of services to expedite and streamline the research process, enables our biopharmaceutical company clients to harness the drug development expertise of the Lupus Clinical Investigators Network (LuCIN) key opinion leaders, who are luminaries in the field.
Medical and Scientific Consulting
The Lupus Therapeutics Consulting service, part of our full suite of services to expedite and streamline the research process, enables our biopharmaceutical company clients to harness the drug development expertise of the Lupus Clinical Investigators Network (LuCIN) key opinion leaders, who are luminaries in the field.
Medical and Scientific Consulting
The Lupus Therapeutics Consulting service, part of our full suite of services to expedite and streamline the research process, enables our biopharmaceutical company clients to harness the drug development expertise of the Lupus Clinical Investigators Network (LuCIN) key opinion leaders, who are luminaries in the field.

Synergistic Collaboration
The Lupus Therapeutics Consulting service connects this network with our industry partners for synergistic collaboration on lupus clinical research development and planning. Through this effort we seek to improve the quality and outcomes of our clients’ lupus clinical trials, improve recruitment rates, and significantly reduce the barriers in the trial process.
Early Engagement
Early engagement between industry and LuCIN through the Lupus Therapeutics Consulting service leads to more effective clinical development plans and pragmatic study designs, resulting in faster development and launch of potential new therapies for people with lupus.


Synergistic Collaboration
The Lupus Therapeutics Consulting service connects this network with our industry partners for synergistic collaboration on lupus clinical research development and planning. Through this effort we seek to improve the quality and outcomes of our clients’ lupus clinical trials, improve recruitment rates, and significantly reduce the barriers in the trial process.

Early Engagement
Early engagement between industry and LuCIN through the Lupus Therapeutics Consulting service leads to more effective clinical development plans and pragmatic study designs, resulting in faster development and launch of potential new therapies for people with lupus.





